NCT02772055

Brief Summary

This is a multicentre, randomised, single blinded, parallel-group design clinical trial to assess the effect of moxa smoke in the treatment using moxibustion for Knee Osteoarthritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
138

participants targeted

Target at P75+ for not_applicable pain

Timeline
Completed

Started May 2016

Longer than P75 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

May 10, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 13, 2016

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

February 17, 2020

Status Verified

February 1, 2020

Enrollment Period

3 years

First QC Date

May 10, 2016

Last Update Submit

February 13, 2020

Conditions

Keywords

Moxa smokeMoxibustionKnee osteoarthritis

Outcome Measures

Primary Outcomes (1)

  • Change in the global scale value of the Western Ontario and McMaster Osteoarthritis Index(WOMAC) score

    4 weeks from baseline

Secondary Outcomes (3)

  • Change in the WOMAC subscales (pain, stiffness, and function)

    at baseline(0 week), 2 weeks, 4weeks, 8 weeks and 12 weeks later after allocation

  • Mean change in Visual Analogue Scale for the pain intensity

    Assessing participants at baseline(0 week), 2 weeks, 4weeks, 8 weeks and 12 weeks later after allocation

  • Change of Patient global assessment score

    at 2 weeks, 4weeks, 8 weeks and 12 weeks later after allocation

Study Arms (2)

moxibustion group

EXPERIMENTAL

Conventional moxibustion treatment for knee osteoarthritis participants.12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.

Other: Moxibustion

smoke-free moxibustion group

EXPERIMENTAL

Conventional moxibustion treatment for knee osteoarthritis participants and have a purification device at the top of the moxibustion to remove the moxa smoke.12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.

Other: MoxibustionOther: Moxa smoke purification device

Interventions

Moxibustion at three acupuncture point(EX-LE04,ST35,ST36).12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.

moxibustion groupsmoke-free moxibustion group

Investigators place a purification device(Shenzhen Conyson Electronic Technology Co, Ltd,C200 moxa smoke purification device,Shenzhen,China) at the top of the moxibustion to remove the moxa smoke.

smoke-free moxibustion group

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants meeting the following criteria will be included:
  • aged between 40 and 75 years
  • diagnosed with knee osteoarthritis formulated by the American College of Rheumatology (ACR).
  • the average severity of knee pain not more than 7 points on a visual analogue scale for most days during the past month
  • agree not have the paregoric during the whole treatment phase
  • willingness to participate in a randomized study and to sign the informed consent form.

You may not qualify if:

  • Participants will be excluded if they have these experiences:
  • inflammatory diseases, including rheumatoid arthritis, cancer, traumatic injury that might be related to the current knee pai
  • autoimmune disease, uncontrolled hypertension
  • diabetes mellitus requiring insulin injection
  • life-threatening cardiovascular or neurological events within the past year
  • chronic respiratory disease,a haemorrhagic disorder
  • alcohol or drug addiction
  • an active infectious disease including tuberculosis
  • a significant knee joint deformity
  • knee replacement surgery for the affected knee
  • knee arthroscopy within the past year
  • steroid injection in the knee joints within the past 3 months
  • injections in the knee joints or joint fluid injection within the past 6 months
  • accept acupuncture, moxibustion, cupping, or herbal medicine within the past 4 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chengdu University of Traditional Chinese Medicine

Chengdu, Sichuan, 610075, China

Location

Related Publications (2)

  • Luo L, Liao M, Peng JX, Ma Q, Zhou JY, Zhu LL, Wang X, Chen SS, Yin HY, Wu QF, Zhang CS, Lv P, Tang Y, Yu SG. Comparison of the Efficacy between Conventional Moxibustion and Smoke-Free Moxibustion on Knee Osteoarthritis: A Randomized Controlled Trial. Evid Based Complement Alternat Med. 2019 Mar 14;2019:1291947. doi: 10.1155/2019/1291947. eCollection 2019.

  • Zhu LL, Zhou JY, Luo L, Wang X, Peng JX, Chen SS, Yin HY, Wu QF, Zhang CS, Lv P, Tang Y, Yu SG. Comparison of the efficacy between conventional moxibustion and smoke-free moxibustion on knee osteoarthritis: study protocol of a randomized controlled trial. Trials. 2017 Apr 24;18(1):188. doi: 10.1186/s13063-017-1846-2.

MeSH Terms

Conditions

PainOsteoarthritis, Knee

Interventions

Moxibustion

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsOsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Acupuncture TherapyComplementary TherapiesTherapeutics

Study Officials

  • Yu Shuguang, Professor

    Chengdu University of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2016

First Posted

May 13, 2016

Study Start

May 1, 2016

Primary Completion

May 1, 2019

Study Completion

December 1, 2019

Last Updated

February 17, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations